<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36355108</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2218-1989</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Metabolites</Title><ISOAbbreviation>Metabolites</ISOAbbreviation></Journal><ArticleTitle>Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1026</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/metabo12111026</ELocationID><Abstract><AbstractText>Exercise intolerance is a major manifestation of post-acute sequelae of severe acute respiratory syndrome coronavirus infection (PASC, or "long-COVID"). Exercise intolerance in PASC is associated with higher arterial blood lactate accumulation and lower fatty acid oxidation rates during graded exercise tests to volitional exertion, suggesting altered metabolism and mitochondrial dysfunction. It remains unclear whether the profound disturbances in metabolism that have been identified in plasma from patients suffering from acute coronavirus disease 2019 (COVID-19) are also present in PASC. To bridge this gap, individuals with a history of previous acute COVID-19 infection that did not require hospitalization were enrolled at National Jewish Health (Denver, CO, USA) and were grouped into those that developed PASC (n = 29) and those that fully recovered (n = 16). Plasma samples from the two groups were analyzed via mass spectrometry-based untargeted metabolomics and compared against plasma metabolic profiles of healthy control individuals (n = 30). Observational demographic and clinical data were retrospectively abstracted from the medical record. Compared to plasma of healthy controls or individuals who recovered from COVID-19, PASC plasma exhibited significantly higher free- and carnitine-conjugated mono-, poly-, and highly unsaturated fatty acids, accompanied by markedly lower levels of mono-, di- and tricarboxylates (pyruvate, lactate, citrate, succinate, and malate), polyamines (spermine) and taurine. Plasma from individuals who fully recovered from COVID-19 exhibited an intermediary metabolic phenotype, with milder disturbances in fatty acid metabolism and higher levels of spermine and taurine. Of note, depletion of tryptophan-a hallmark of disease severity in COVID-19-is not normalized in PASC patients, despite normalization of kynurenine levels-a tryptophan metabolite that predicts mortality in hospitalized COVID-19 patients. In conclusion, PASC plasma metabolites are indicative of altered fatty acid metabolism and dysfunctional mitochondria-dependent lipid catabolism. These metabolic profiles obtained at rest are consistent with previously reported mitochondrial dysfunction during exercise, and may pave the way for therapeutic intervention focused on restoring mitochondrial fat-burning capacity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guntur</LastName><ForeName>Vamsi P</ForeName><Initials>VP</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nemkov</LastName><ForeName>Travis</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8566-7119</Identifier><AffiliationInfo><Affiliation>Department of Biochemical and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Boer</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohning</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baraghoshi</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-9485-9267</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cendali</LastName><ForeName>Francesca I</ForeName><Initials>FI</Initials><Identifier Source="ORCID">0000-0002-8874-2150</Identifier><AffiliationInfo><Affiliation>Department of Biochemical and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>San-Mill&#xe1;n</LastName><ForeName>Inigo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Physiology and Nutrition, University of Colorado, Colorado Springs, CO 80918, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrache</LastName><ForeName>Irina</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-1094-2600</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alessandro</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2258-6490</Identifier><AffiliationInfo><Affiliation>Department of Biochemical and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL146442</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RM1 GM131968</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL077328</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL007085</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL148151</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 HL150032</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL149714</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RM1GM131968</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL161004</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Metabolites</MedlineTA><NlmUniqueID>101578790</NlmUniqueID><ISSNLinking>2218-1989</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">exercise intolerance</Keyword><Keyword MajorTopicYN="N">keyword post-acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">plasma</Keyword></KeywordList><CoiStatement>VPG: received consultant fees from AstraZeneca and Regeneron, unrelated to this report. TN: Co-founder of Omix Technologies and Altis Biosciences, has patents unrelated to this report. ISM: Co-founder of Altis Biosciences. IP: received consultant fees from Ceramedix and Allinaire Therapeutics. Has patents unrelated to this report. Serves on the board of the American Thoracic Society. AD: Co-founder of Omix Technologies and Altis Biosciences, advisory board member of Hemanext and Forma Therapeutics, has patents unrelated to this report. All other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36355108</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pii">metabo12111026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>De Boer E., Petrache I., Goldstein N.M., Olin J.T., Keith R.C., Modena B., Mohning M.P., Yunt Z.X., San-Mill&#xe1;n I., Swigris J.J. Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome. Am. J. Respir. Crit. Care Med. 2022;205:126&#x2013;129. doi: 10.1164/rccm.202108-1903LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1903LE</ArticleId><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>De Boer E., Petrache I., Mohning M.P. Cardiopulmonary Exercise Testing. JAMA. 2022;327:1284&#x2013;1285. doi: 10.1001/jama.2022.2037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.2037</ArticleId><ArticleId IdType="pubmed">35266955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang C., Liu Z., Zhu Y., Lu J., Ge C., Zhang C., Li N., Jin N., Li Y., Tian M., et al. SARS-CoV-2 Causes Mitochondrial Dysfunction and Mitophagy Impairment. Front. Microbiol. 2021;12:780768. doi: 10.3389/fmicb.2021.780768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.780768</ArticleId><ArticleId IdType="pmc">PMC8770829</ArticleId><ArticleId IdType="pubmed">35069483</ArticleId></ArticleIdList></Reference><Reference><Citation>Longo N., Frigeni M., Pasquali M. Carnitine transport and fatty acid oxidation. Biochim. Biophys. Acta. 2016;1863:2422&#x2013;2435. doi: 10.1016/j.bbamcr.2016.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2016.01.023</ArticleId><ArticleId IdType="pmc">PMC4967041</ArticleId><ArticleId IdType="pubmed">26828774</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane D.A. Lactate oxidation at the mitochondria: A lactate-malate-aspartate shuttle at work. Front. Neurosci. 2014;8:366. doi: 10.3389/fnins.2014.00366.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00366</ArticleId><ArticleId IdType="pmc">PMC4243568</ArticleId><ArticleId IdType="pubmed">25505376</ArticleId></ArticleIdList></Reference><Reference><Citation>Danlos F.X., Grajeda-Iglesias C., Durand S., Sauvat A., Roumier M., Cantin D., Colomba E., Rohmer J., Pommeret F., Baciarello G., et al. Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 2021;12:258. doi: 10.1038/s41419-021-03540-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03540-y</ArticleId><ArticleId IdType="pmc">PMC7948172</ArticleId><ArticleId IdType="pubmed">33707411</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbraith M.D., Kinning K.T., Sullivan K.D., Araya P., Smith K.P., Granrath R.E., Shaw J.R., Baxter R., Jordan K.R., Russell S., et al. Specialized interferon action in COVID-19. Proc. Natl. Acad. Sci. USA. 2022;119:e2116730119. doi: 10.1073/pnas.2116730119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2116730119</ArticleId><ArticleId IdType="pmc">PMC8931386</ArticleId><ArticleId IdType="pubmed">35217532</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbraith M.D., Kinning K.T., Sullivan K.D., Baxter R., Araya P., Jordan K.R., Russell S., Smith K.P., Granrath R.E., Shaw J.R., et al. Seroconversion stages COVID19 into distinct pathophysiological states. Elife. 2021;10:e65508. doi: 10.7554/eLife.65508.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.65508</ArticleId><ArticleId IdType="pmc">PMC7963480</ArticleId><ArticleId IdType="pubmed">33724185</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Dzieciatkowska M., Issaian A., Nemkov T., Hill R.C., Francis R.O., Hudson K.E., Buehler P.W., Zimring J.C., et al. Evidence for structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. medRxiv. 2020;19:4455&#x2013;4469. doi: 10.1021/acs.jproteome.0c00606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00606</ArticleId><ArticleId IdType="pmc">PMC7640979</ArticleId><ArticleId IdType="pubmed">33103907</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J.A., Nemkov T., Bertolone L., Francis R.O., Hudson K.E., Zimring J.C., Hansen K.C., Hod E.A., et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5:e140327. doi: 10.1172/jci.insight.140327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alessandro A., Thomas T., Akpan I.J., Reisz J.A., Cendali F.I., Gamboni F., Nemkov T., Thangaraju K., Katneni U., Tanaka K., et al. Biological and Clinical Factors Contributing to the Metabolic Heterogeneity of Hospitalized Patients with and without COVID-19. Cells. 2021;10:2293. doi: 10.3390/cells10092293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10092293</ArticleId><ArticleId IdType="pmc">PMC8467961</ArticleId><ArticleId IdType="pubmed">34571942</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B., Chu H., Yang D., Sze K.H., Lai P.M., Yuan S., Shuai H., Wang Y., Kao R.Y., Chan J.F., et al. Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication. Viruses. 2019;11:73. doi: 10.3390/v11010073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010073</ArticleId><ArticleId IdType="pmc">PMC6357182</ArticleId><ArticleId IdType="pubmed">30654597</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller C., Hardt M., Schwudke D., Neuman B.W., Pleschka S., Ziebuhr J. Inhibition of Cytosolic Phospholipase A(2)&#x3b1; Impairs an Early Step of Coronavirus Replication in Cell Culture. J. Virol. 2018;92:e01463-17. doi: 10.1128/JVI.01463-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01463-17</ArticleId><ArticleId IdType="pmc">PMC5790932</ArticleId><ArticleId IdType="pubmed">29167338</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann M.R., George De la Rosa M.V., Rosania G.R., Stringer K.A. L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine. Metabolites. 2021;11:51. doi: 10.3390/metabo11010051.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11010051</ArticleId><ArticleId IdType="pmc">PMC7829830</ArticleId><ArticleId IdType="pubmed">33466750</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E., Timo S., Amede E., Vanella V.V., Puricelli C., Cappellano G., Raineri D., Cittone M.G., Rizzi E., Pedrinelli A.R., et al. Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2. Int. J. Mol. Sci. 2020;21:8623. doi: 10.3390/ijms21228623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228623</ArticleId><ArticleId IdType="pmc">PMC7696386</ArticleId><ArticleId IdType="pubmed">33207699</ArticleId></ArticleIdList></Reference><Reference><Citation>Liptak P., Baranovicova E., Rosolanka R., Simekova K., Bobcakova A., Vysehradsky R., Duricek M., Dankova Z., Kapinova A., Dvorska D., et al. Persistence of Metabolomic Changes in Patients during Post-COVID Phase: A Prospective, Observational Study. Metabolites. 2022;12:641. doi: 10.3390/metabo12070641.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070641</ArticleId><ArticleId IdType="pmc">PMC9321209</ArticleId><ArticleId IdType="pubmed">35888766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Luo P., Xu J., Yang L., Ma P., Tan X., Chen Q., Zhou M., Song S., Xia H., et al. Plasma Metabolomic Profiles in Recovered COVID-19 Patients without Previous Underlying Diseases 3 Months After Discharge. J. Inflamm. Res. 2021;14:4485&#x2013;4501. doi: 10.2147/JIR.S325853.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S325853</ArticleId><ArticleId IdType="pmc">PMC8434912</ArticleId><ArticleId IdType="pubmed">34522117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemkov T., Hansen K.C., D&#x2019;Alessandro A. A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways. Rapid Commun. Mass Spectrom. 2017;31:663&#x2013;673. doi: 10.1002/rcm.7834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcm.7834</ArticleId><ArticleId IdType="pmc">PMC5364945</ArticleId><ArticleId IdType="pubmed">28195377</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemkov T., Reisz J.A., Gehrke S., Hansen K.C., D&#x2019;Alessandro A. High-Throughput Metabolomics: Isocratic and Gradient Mass Spectrometry-Based Methods. Methods Mol. Biol. 2019;1978:13&#x2013;26. doi: 10.1007/978-1-4939-9236-2_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9236-2_2</ArticleId><ArticleId IdType="pubmed">31119654</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisz J.A., Zheng C., D&#x2019;Alessandro A., Nemkov T. Untargeted and Semi-targeted Lipid Analysis of Biological Samples Using Mass Spectrometry-Based Metabolomics. Methods Mol. Biol. 2019;1978:121&#x2013;135. doi: 10.1007/978-1-4939-9236-2_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9236-2_8</ArticleId><ArticleId IdType="pubmed">31119660</ArticleId></ArticleIdList></Reference><Reference><Citation>Clasquin M.F., Melamud E., Rabinowitz J.D. LC-MS data processing with MAVEN: A metabolomic analysis and visualization engine. Curr. Protoc. Bioinform. 2012;1:14.11.1&#x2013;14.11.23. doi: 10.1002/0471250953.bi1411s37. Chapter 14, Unit14 11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471250953.bi1411s37</ArticleId><ArticleId IdType="pmc">PMC4055029</ArticleId><ArticleId IdType="pubmed">22389014</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Ryan-Murua P., Rodr&#xed;guez-Jim&#xe9;nez J., Palacios-Ce&#xf1;a M., Arendt-Nielsen L., Torres-Macho J. Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors. Respiration. 2022;101:658&#x2013;665. doi: 10.1159/000524042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000524042</ArticleId><ArticleId IdType="pmc">PMC9148886</ArticleId><ArticleId IdType="pubmed">35381597</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I., Wright Muelas M., Taylor J.M., Davison A.S., Xu Y., Grixti J.M., Gotts N., Sorokin A., Goodacre R., Kell D.B. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics. 2021;18:6. doi: 10.1007/s11306-021-01859-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-021-01859-3</ArticleId><ArticleId IdType="pmc">PMC8686810</ArticleId><ArticleId IdType="pubmed">34928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonanad C., Garcia-Blas S., Tarazona-Santabalbina F., Sanchis J., Bertomeu-Gonzalez V., Facila L., Ariza A., Nunez J., Cordero A. The Effect of Age on Mortality in Patients with COVID-19: A Meta-Analysis with 611,583 Subjects. J. Am. Med. Dir. Assoc. 2020;21:915&#x2013;918. doi: 10.1016/j.jamda.2020.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.05.045</ArticleId><ArticleId IdType="pmc">PMC7247470</ArticleId><ArticleId IdType="pubmed">32674819</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift A.K., Coupland C.A.C., Keogh R.H., Hemingway H., Hippisley-Cox J. COVID-19 Mortality Risk in Down Syndrome: Results from a Cohort Study of 8 Million Adults. Ann. Intern. Med. 2020;174:572&#x2013;576. doi: 10.7326/M20-4986.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4986</ArticleId><ArticleId IdType="pmc">PMC7592804</ArticleId><ArticleId IdType="pubmed">33085509</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P., Ssentongo A.E., Heilbrunn E.S., Ba D.M., Chinchilli V.M. Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis. PLoS ONE. 2020;15:e0238215. doi: 10.1371/journal.pone.0238215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238215</ArticleId><ArticleId IdType="pmc">PMC7449476</ArticleId><ArticleId IdType="pubmed">32845926</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J. Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Vamsi G., Brian M., Claudia O., Shu-Yi L., Pearlanne Z., Jared E., Rebecca K., Rachel D., Irina P., Nir G. Predictive characteristics of prolonged symptoms and seroconversion in ambulatory patients recovering from SARS-CoV-2 infection. Southwest Respir. Crit. Care Chron. 2022;10:1&#x2013;9. doi: 10.12746/swrccc.v10i44.1035.</Citation><ArticleIdList><ArticleId IdType="doi">10.12746/swrccc.v10i44.1035</ArticleId></ArticleIdList></Reference><Reference><Citation>Vald&#xe9;s A., Moreno L.O., Rello S.R., Ordu&#xf1;a A., Bernardo D., Cifuentes A. Metabolomics study of COVID-19 patients in four different clinical stages. Sci. Rep. 2022;12:1650. doi: 10.1038/s41598-022-05667-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-05667-0</ArticleId><ArticleId IdType="pmc">PMC8803913</ArticleId><ArticleId IdType="pubmed">35102215</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement C.C., D&#x2019;Alessandro A., Thangaswamy S., Chalmers S., Furtado R., Spada S., Mondanelli G., Ianni F., Gehrke S., Gargaro M., et al. 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. Nat. Commun. 2021;12:4447. doi: 10.1038/s41467-021-24785-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24785-3</ArticleId><ArticleId IdType="pmc">PMC8295276</ArticleId><ArticleId IdType="pubmed">34290243</ArticleId></ArticleIdList></Reference><Reference><Citation>Longobardi I., Prado D., Goessler K.F., Meletti M.M., de Oliveira J&#xfa;nior G.N., de Andrade D.C.O., Gualano B., Roschel H. Oxygen uptake kinetics and chronotropic responses to exercise are impaired in survivors of severe COVID-19. Am. J. Physiol. Heart Circ. Physiol. 2022;323:H569&#x2013;H576. doi: 10.1152/ajpheart.00291.2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00291.2022</ArticleId><ArticleId IdType="pmc">PMC9448283</ArticleId><ArticleId IdType="pubmed">35984763</ArticleId></ArticleIdList></Reference><Reference><Citation>Spriet L.L., Howlett R.A., Heigenhauser G.J. An enzymatic approach to lactate production in human skeletal muscle during exercise. Med. Sci. Sports Exerc. 2000;32:756&#x2013;763. doi: 10.1097/00005768-200004000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005768-200004000-00007</ArticleId><ArticleId IdType="pubmed">10776894</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks G.A. Lactate as a fulcrum of metabolism. Redox Biol. 2020;35:101454. doi: 10.1016/j.redox.2020.101454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101454</ArticleId><ArticleId IdType="pmc">PMC7284908</ArticleId><ArticleId IdType="pubmed">32113910</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Wu J., Zhu J., Kuei C., Yu J., Shelton J., Sutton S.W., Li X., Yun S.J., Mirzadegan T., et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J. Biol. Chem. 2009;284:2811&#x2013;2822. doi: 10.1074/jbc.M806409200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M806409200</ArticleId><ArticleId IdType="pubmed">19047060</ArticleId></ArticleIdList></Reference><Reference><Citation>San-Millan I., Sparagna G.C., Chapman H.L., Warkins V.L., Chatfield K.C., Shuff S.R., Martinez J.L., Brooks G.A. Chronic Lactate Exposure Decreases Mitochondrial Function by Inhibition of Fatty Acid Uptake and Cardiolipin Alterations in Neonatal Rat Cardiomyocytes. Front. Nutr. 2022;9:809485. doi: 10.3389/fnut.2022.809485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.809485</ArticleId><ArticleId IdType="pmc">PMC8931465</ArticleId><ArticleId IdType="pubmed">35308271</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemkov T., Skinner S., Diaw M., Diop S., Samb A., Connes P., D&#x2019;Alessandro A. Plasma Levels of Acyl-Carnitines and Carboxylic Acids Correlate with Cardiovascular and Kidney Function in Subjects with Sickle Cell Trait. Front. Physiol. 2022;13:916197. doi: 10.3389/fphys.2022.916197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.916197</ArticleId><ArticleId IdType="pmc">PMC9326174</ArticleId><ArticleId IdType="pubmed">35910560</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi G., Bozzini C., Bertolone L., Dima F., Busti F., Castagna A., Stranieri C., Fratta Pasini A.M., Friso S., Lippi G., et al. Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19. Front. Physiol. 2022;13:932013. doi: 10.3389/fphys.2022.932013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.932013</ArticleId><ArticleId IdType="pmc">PMC9289213</ArticleId><ArticleId IdType="pubmed">35860651</ArticleId></ArticleIdList></Reference><Reference><Citation>Recktenwald S.M., Simionato G., Lopez M.G.M., Gamboni F., Dzieciatkowska M., Meybohm P., Zacharowski K., Knethen A.v., Wagner C., Kaestner L., et al. Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19. medRxiv. 2022 doi: 10.1101/2022.03.31.22273226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.31.22273226</ArticleId><ArticleId IdType="pmc">PMC9767455</ArticleId><ArticleId IdType="pubmed">36537079</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A., Tellone E., Barreca D., Ficarra S., Lagan&#xe0; G. Implication of COVID-19 on Erythrocytes Functionality: Red Blood Cell Biochemical Implications and Morpho-Functional Aspects. Int. J. Mol. Sci. 2022;23:2171. doi: 10.3390/ijms23042171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042171</ArticleId><ArticleId IdType="pmc">PMC8878454</ArticleId><ArticleId IdType="pubmed">35216286</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihalik S.J., Goodpaster B.H., Kelley D.E., Chace D.H., Vockley J., Toledo F.G.S., DeLany J.P. Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity. Obesity. 2010;18:1695&#x2013;1700. doi: 10.1038/oby.2009.510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/oby.2009.510</ArticleId><ArticleId IdType="pmc">PMC3984458</ArticleId><ArticleId IdType="pubmed">20111019</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams S.H., Hoppel C.L., Lok K.H., Zhao L., Wong S.W., Minkler P.E., Hwang D.H., Newman J.W., Garvey W.T. Plasma Acylcarnitine Profiles Suggest Incomplete Long-Chain Fatty Acid &#x3b2;-Oxidation and Altered Tricarboxylic Acid Cycle Activity in Type 2 Diabetic African-American Women. J. Nutr. 2009;139:1073&#x2013;1081. doi: 10.3945/jn.108.103754.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.108.103754</ArticleId><ArticleId IdType="pmc">PMC2714383</ArticleId><ArticleId IdType="pubmed">19369366</ArticleId></ArticleIdList></Reference><Reference><Citation>Newgard C.B., An J., Bain J.R., Muehlbauer M.J., Stevens R.D., Lien L.F., Haqq A.M., Shah S.H., Arlotto M., Slentz C.A., et al. A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance. Cell Metab. 2009;9:311&#x2013;326. doi: 10.1016/j.cmet.2009.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2009.02.002</ArticleId><ArticleId IdType="pmc">PMC3640280</ArticleId><ArticleId IdType="pubmed">19356713</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Liang L., Gao X., Zhang H., Yao P., Hu Y., Ma Y., Wang F., Jin Q., Li H., et al. Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study. Diabetes Care. 2016;39:1563&#x2013;1570. doi: 10.2337/dc16-0232.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc16-0232</ArticleId><ArticleId IdType="pubmed">27388475</ArticleId></ArticleIdList></Reference><Reference><Citation>Batchuluun B., Al Rijjal D., Prentice K.J., Eversley J.A., Burdett E., Mohan H., Bhattacharjee A., Gunderson E.P., Liu Y., Wheeler M.B. Elevated Medium-Chain Acylcarnitines Are Associated With Gestational Diabetes Mellitus and Early Progression to Type 2 Diabetes and Induce Pancreatic &#x3b2;-Cell Dysfunction. Diabetes. 2018;67:885&#x2013;897. doi: 10.2337/db17-1150.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db17-1150</ArticleId><ArticleId IdType="pmc">PMC5910003</ArticleId><ArticleId IdType="pubmed">29436377</ArticleId></ArticleIdList></Reference><Reference><Citation>Langley R.J., Tsalik E.L., van Velkinburgh J.C., Glickman S.W., Rice B.J., Wang C., Chen B., Carin L., Suarez A., Mohney R.P., et al. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci. Transl. Med. 2013;5:195ra195. doi: 10.1126/scitranslmed.3005893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005893</ArticleId><ArticleId IdType="pmc">PMC3924586</ArticleId><ArticleId IdType="pubmed">23884467</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung K.P., Chen G.Y., Chuang T.Y., Huang Y.T., Chang H.T., Chen Y.F., Liu W.L., Chen Y.J., Hsu C.L., Huang M.T., et al. Increased Plasma Acetylcarnitine in Sepsis Is Associated With Multiple Organ Dysfunction and Mortality: A Multicenter Cohort Study. Crit. Care Med. 2019;47:210&#x2013;218. doi: 10.1097/CCM.0000000000003517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003517</ArticleId><ArticleId IdType="pubmed">30379669</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarich M.A., Evans C.R., Karnovsky A., Das A.K., Jones A.E., Stringer K.A. Septic Shock Nonsurvivors Have Persistently Elevated Acylcarnitines Following Carnitine Supplementation. Shock. 2018;49:412&#x2013;419. doi: 10.1097/SHK.0000000000000997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000997</ArticleId><ArticleId IdType="pmc">PMC5847421</ArticleId><ArticleId IdType="pubmed">29384504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario M., Cambiaghi A., Brunelli L., Giordano S., Caironi P., Guatteri L., Raimondi F., Gattinoni L., Latini R., Masson S., et al. Mortality prediction in patients with severe septic shock: A pilot study using a target metabolomics approach. Sci. Rep. 2016;6:20391. doi: 10.1038/srep20391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20391</ArticleId><ArticleId IdType="pmc">PMC4742912</ArticleId><ArticleId IdType="pubmed">26847922</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers A.J., McGeachie M., Baron R.M., Gazourian L., Haspel J.A., Nakahira K., Fredenburgh L.E., Hunninghake G.M., Raby B.A., Matthay M.A., et al. Metabolomic Derangements Are Associated with Mortality in Critically Ill Adult Patients. PLoS ONE. 2014;9:e87538. doi: 10.1371/journal.pone.0087538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087538</ArticleId><ArticleId IdType="pmc">PMC3907548</ArticleId><ArticleId IdType="pubmed">24498130</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemkov T., Skinner S.C., Nader E., Stefanoni D., Robert M., Cendali F., Stauffer E., Cibiel A., Boisson C., Connes P., et al. Acute Cycling Exercise Induces Changes in Red Blood Cell Deformability and Membrane Lipid Remodeling. Int. J. Mol. Sci. 2021;22:896. doi: 10.3390/ijms22020896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020896</ArticleId><ArticleId IdType="pmc">PMC7831009</ArticleId><ArticleId IdType="pubmed">33477427</ArticleId></ArticleIdList></Reference><Reference><Citation>San-Mill&#xe1;n I., Stefanoni D., Martinez J.L., Hansen K.C., D&#x2019;Alessandro A., Nemkov T. Metabolomics of Endurance Capacity in World Tour Professional Cyclists. Front. Physiol. 2020;11:578. doi: 10.3389/fphys.2020.00578.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00578</ArticleId><ArticleId IdType="pmc">PMC7291837</ArticleId><ArticleId IdType="pubmed">32581847</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemkov T., Cendali F., Stefanoni D., Martinez J.L., Hansen K.C., San-Mill&#xe1;n I., D&#x2019;Alessandro A. Metabolic Signatures of Performance in Elite World Tour Professional Cyclists. bioRxiv. 2022 doi: 10.1101/2022.09.13.507793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.13.507793</ArticleId><ArticleId IdType="pmc">PMC10163861</ArticleId><ArticleId IdType="pubmed">37148487</ArticleId></ArticleIdList></Reference><Reference><Citation>San-Mill&#xe1;n I., Brooks G.A. Assessment of Metabolic Flexibility by Means of Measuring Blood Lactate, Fat, and Carbohydrate Oxidation Responses to Exercise in Professional Endurance Athletes and Less-Fit Individuals. Sports Med. 2018;48:467&#x2013;479. doi: 10.1007/s40279-017-0751-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-017-0751-x</ArticleId><ArticleId IdType="pubmed">28623613</ArticleId></ArticleIdList></Reference><Reference><Citation>Festa L., Tarperi C., Skroce K., Boccia G., Lippi G., La Torre A., Schena F. Effects of Flywheel Strength Training on the Running Economy of Recreational Endurance Runners. J. Strength Cond. Res. 2019;33:684&#x2013;690. doi: 10.1519/JSC.0000000000002973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1519/JSC.0000000000002973</ArticleId><ArticleId IdType="pubmed">30570511</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Eijk L.E., Offringa A.K., Bernal M.E., Bourgonje A.R., van Goor H., Hillebrands J.L. The Disease-Modifying Role of Taurine and Its Therapeutic Potential in Coronavirus Disease 2019 (COVID-19) Adv. Exp. Med. Biol. 2022;1370:3&#x2013;21. doi: 10.1007/978-3-030-93337-1_1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-93337-1_1</ArticleId><ArticleId IdType="pubmed">35882777</ArticleId></ArticleIdList></Reference><Reference><Citation>Almulla A.F., Supasitthumrong T., Tunvirachaisakul C., Algon A.A.A., Al-Hakeim H.K., Maes M. The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: A systematic review and meta-analysis. BMC Infect. Dis. 2022;22:615. doi: 10.1186/s12879-022-07582-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07582-1</ArticleId><ArticleId IdType="pmc">PMC9284970</ArticleId><ArticleId IdType="pubmed">35840908</ArticleId></ArticleIdList></Reference><Reference><Citation>Cihan M., Do&#x11f;an &#xd6;., Ceran Serdar C., Altun&#xe7;eki&#xe7; Y&#x131;ld&#x131;r&#x131;m A., Kurt C., Serdar M.A. Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis. J. Clin. Lab. Anal. 2022;36:e24257. doi: 10.1002/jcla.24257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24257</ArticleId><ArticleId IdType="pmc">PMC8906035</ArticleId><ArticleId IdType="pubmed">35092710</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewulf J.P., Martin M., Marie S., Oguz F., Belkhir L., De Greef J., Yombi J.C., Wittebole X., Laterre P.F., Jadoul M., et al. Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19. Sci. Rep. 2022;12:9959. doi: 10.1038/s41598-022-14292-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-14292-w</ArticleId><ArticleId IdType="pmc">PMC9198612</ArticleId><ArticleId IdType="pubmed">35705608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorriento D., Di Vaia E., Iaccarino G. Physical Exercise: A Novel Tool to Protect Mitochondrial Health. Front. Physiol. 2021;12:660068. doi: 10.3389/fphys.2021.660068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.660068</ArticleId><ArticleId IdType="pmc">PMC8110831</ArticleId><ArticleId IdType="pubmed">33986694</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietrangelo T., Di Filippo E.S., Mancinelli R., Doria C., Rotini A., Fan&#xf2;-Illic G., Fulle S. Low Intensity Exercise Training Improves Skeletal Muscle Regeneration Potential. Front. Physiol. 2015;6:399. doi: 10.3389/fphys.2015.00399.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2015.00399</ArticleId><ArticleId IdType="pmc">PMC4689811</ArticleId><ArticleId IdType="pubmed">26733888</ArticleId></ArticleIdList></Reference><Reference><Citation>Liepinsh E., Makarova E., Plakane L., Konrade I., Liepins K., Videja M., Sevostjanovs E., Grinberga S., Makrecka-Kuka M., Dambrova M. Low-intensity exercise stimulates bioenergetics and increases fat oxidation in mitochondria of blood mononuclear cells from sedentary adults. Physiol. Rep. 2020;8:e14489. doi: 10.14814/phy2.14489.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14489</ArticleId><ArticleId IdType="pmc">PMC7305243</ArticleId><ArticleId IdType="pubmed">32562386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawagoshi A., Kiyokawa N., Sugawara K., Takahashi H., Sakata S., Satake M., Shioya T. Effects of low-intensity exercise and home-based pulmonary rehabilitation with pedometer feedback on physical activity in elderly patients with chronic obstructive pulmonary disease. Respir. Med. 2015;109:364&#x2013;371. doi: 10.1016/j.rmed.2015.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2015.01.008</ArticleId><ArticleId IdType="pubmed">25682543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortianou E.A., Nasis I.G., Spetsioti S.T., Daskalakis A.M., Vogiatzis I. Effectiveness of Interval Exercise Training in Patients with COPD. Cardiopulm. Phys. Ther. J. 2010;21:12&#x2013;19. doi: 10.1097/01823246-201021030-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01823246-201021030-00004</ArticleId><ArticleId IdType="pmc">PMC2941353</ArticleId><ArticleId IdType="pubmed">20957074</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>